Senior insider sale
Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC — senior position signals high conviction
$10.26M
80.18K shares
What this filing means
ONYIA JUDE plans to sell 80.18K shares of NEUROCRINE BIOSCIENCES INC valued at approximately $10.26M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2025ACC: 0001950047-25-004804
Officer· Chief Scientific Officer
Since Nov 2021
80.18K
Shares to sell
$10.26M
Approx. market value
80.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/2/2025
80.18KTotal acquired80.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/2/2025 | Exercise of Stock Options Cash | 80.18K | — |
| Total | 80.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
80.18K
Market value
$10.26M
7/2/2025
Total
Units
80.18K
Value
$10.26M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/2/2025 | 80.18K | $10.26M | NASDAQ | Planned |
| Total | 80.18K | $10.26M | ||